GR1001151B - Νεα xρηση θειορεδοξινης - Google Patents

Νεα xρηση θειορεδοξινης

Info

Publication number
GR1001151B
GR1001151B GR900100679A GR900100679A GR1001151B GR 1001151 B GR1001151 B GR 1001151B GR 900100679 A GR900100679 A GR 900100679A GR 900100679 A GR900100679 A GR 900100679A GR 1001151 B GR1001151 B GR 1001151B
Authority
GR
Greece
Prior art keywords
pharmaceutical use
novel pharmaceutical
novel
thioredoxin
malignancies
Prior art date
Application number
GR900100679A
Other languages
Greek (el)
English (en)
Other versions
GR900100679A (en
Inventor
Anders Rosen
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of GR900100679A publication Critical patent/GR900100679A/el
Publication of GR1001151B publication Critical patent/GR1001151B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0036—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y108/00—Oxidoreductases acting on sulfur groups as donors (1.8)
    • C12Y108/01—Oxidoreductases acting on sulfur groups as donors (1.8) with NAD+ or NADP+ as acceptor (1.8.1)
    • C12Y108/01008—Protein-disulfide reductase (1.8.1.8), i.e. thioredoxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
GR900100679A 1989-09-12 1990-09-10 Νεα xρηση θειορεδοξινης GR1001151B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8903003A SE8903003D0 (sv) 1989-09-12 1989-09-12 Novel medical use

Publications (2)

Publication Number Publication Date
GR900100679A GR900100679A (en) 1992-01-20
GR1001151B true GR1001151B (el) 1993-05-24

Family

ID=20376862

Family Applications (1)

Application Number Title Priority Date Filing Date
GR900100679A GR1001151B (el) 1989-09-12 1990-09-10 Νεα xρηση θειορεδοξινης

Country Status (12)

Country Link
EP (1) EP0489113A1 (de)
JP (1) JPH05500216A (de)
AU (1) AU641942B2 (de)
CA (1) CA2065454A1 (de)
DD (1) DD298056A5 (de)
FI (1) FI921058A7 (de)
GR (1) GR1001151B (de)
HU (1) HUT62932A (de)
IE (1) IE903233A1 (de)
PT (1) PT95284A (de)
SE (1) SE8903003D0 (de)
WO (1) WO1991004320A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69303494T2 (de) 1992-11-13 1997-01-16 Idec Pharma Corp Therapeutische verwendung von chimerischen und markierten antikörper gegen menschlichen b lymphozyt beschränkter differenzierung antigen für die behandlung von b-zell-lymphoma
US7744877B2 (en) 1992-11-13 2010-06-29 Biogen Idec Inc. Expression and use of anti-CD20 Antibodies
AU3643497A (en) * 1996-06-28 1998-01-21 National Jewish Center For Immunology And Respiratory Medicine Use of thioredoxin-like molecules for induction of mnsod to treat oxidative damage
CA2274116C (en) * 1996-12-06 2009-05-05 Garth Powis Use, of an inhibitor of thioredoxin, for inhibiting tumor growth
US6689775B2 (en) 1999-06-03 2004-02-10 Arizona Board Of Regents, Acting On Behalf Of The University Of Arizona Uses of thioredoxin
US5919657A (en) * 1997-04-09 1999-07-06 Incyte Pharmaceuticals, Inc. Nucleic acids encoding human thioredoxin protein; related reagents
US7585645B2 (en) 1997-05-27 2009-09-08 Sembiosys Genetics Inc. Thioredoxin and thioredoxin reductase containing oil body based products
IL137177A0 (en) 1998-01-30 2001-07-24 Genesense Technologies Inc Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growth
PL195870B1 (pl) 1998-08-11 2007-11-30 Biogen Idec Inc Zastosowanie przeciwciała anty-CD20, zastosowanieznakowanego radioaktywnie przeciwciała anty-CD20,zastosowanie przeciwciała anty-CD20 do przygotowania leku zwierającego przeciwciało i chemioterapięoraz zastosowanie przeciwciała anty-CD20 do przygotowania leku zawierającego przeciwciało i szpik kostny
DK1616572T3 (da) 1998-11-09 2010-12-06 Biogen Idec Inc Kimært anti-CD20-antistof, rituxan, til anvendelse i behandling af kronisk lymfatisk leukæmi
US8557244B1 (en) 1999-08-11 2013-10-15 Biogen Idec Inc. Treatment of aggressive non-Hodgkins lymphoma with anti-CD20 antibody
WO2002016600A2 (en) * 2000-08-25 2002-02-28 Curagen Corporation Novel proteins and nucleic acids encoding same
KR20050072743A (ko) 2002-09-10 2005-07-12 내셔날 쥬이쉬 메디칼 앤드 리서치 센터 점액 또는 타액의 액화를 위한 생성물 및 방법
WO2014145735A2 (en) 2013-03-15 2014-09-18 Orpro Therapeutics, Inc. Product and process for mucus viscosity normalization

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2633295B2 (ja) * 1987-06-12 1997-07-23 味の素株式会社 ヒトａｄｆをコードする遺伝子

Also Published As

Publication number Publication date
EP0489113A1 (de) 1992-06-10
AU641942B2 (en) 1993-10-07
HUT62932A (en) 1993-06-28
DD298056A5 (de) 1992-02-06
SE8903003D0 (sv) 1989-09-12
WO1991004320A1 (en) 1991-04-04
PT95284A (pt) 1991-08-14
AU6433690A (en) 1991-04-18
HU9200821D0 (en) 1992-05-28
GR900100679A (en) 1992-01-20
JPH05500216A (ja) 1993-01-21
CA2065454A1 (en) 1991-03-13
IE903233A1 (en) 1991-03-27
FI921058A0 (fi) 1992-03-11
FI921058A7 (fi) 1992-03-11

Similar Documents

Publication Publication Date Title
DE3786205D1 (de) Titanocene und deren verwendung.
DE68924026D1 (de) Biosensor und dessen herstellung.
DE68901986D1 (de) Turbomolekularpumpe und deren betriebsverfahren.
IT8567521A1 (it) Apparecchiatura e procedimento per rilevare le variazioni, nel tempo, di caratteristiche di una zona o dell'insieme di una persona, ed applicazioni del procedimento.
DE68924477D1 (de) Gleitkommaeinheit mit gleichzeitiger Multiplikation und Addition.
FI871983A7 (fi) Perfluoripolyeettereitä, jotka eivät sisällä peroksidihappea ja joiden perfluoripolyeetteriketjussa on perfluoriepoksiryhmiä, sekä niiden johdannaisia.
IT8819498A0 (it) Prodotto disinfestante e suo impiego.
NO871581D0 (no) Synergistisk kombinasjon av amantadin og selegilin.
DE69002805D1 (de) Coextrusionsfaehige klebstoffe und damit hergestellte gegenstaende.
TR28384A (tr) Flüoroalifatik -ve karboksil- iceren terminal gruplarina sahip polisilokzanlar, bunlarin hazirlanmasi, ve lifli malzemelerin muamelesinde kullanimlari.
DE3884291D1 (de) Phasenverzögernde Polymerfilme und polarisierende Bauteile.
DE3880480D1 (de) Hemolyse-inhibitor und plastifizierungsmittel.
FI915970A7 (fi) Lääkkeitä, jotka ovat hyödyllisiä syövän hoidossa ja joilla on antihis tamiiniominaisuuksia
DE3780209D1 (de) Dreh- und kipptisch.
DE3887977D1 (de) Buten-1-Polymer-Film und damit laminierter Film.
NO871053D0 (no) Anvendelse av substituerte n-triklormetyltiodikarboksimider i kombinasjon med n,n[-substituerte bis-(2,4-diamino-s-triazin-6-yl)-oligosulfider i vulkaniserbare kautsjukblandinger og slike kautsjukblandinger.
IT8767664A0 (it) Accessorio utilizzabile nel campo pubblicitario e promozionale
FI882538A7 (fi) Antiallergiska och antiinflammatoriska dihydropyridiner.
SE8903003D0 (sv) Novel medical use
NO891122D0 (no) Platinakoordinasjonsforbindelser og anvendelse av forbindelsene i kjemoterapi.
DE3870316D1 (de) Photoinitiator und photopolymerisierbare zusammensetzung damit.
DE3785107D1 (de) Prepreg und dessen komposit.
IT8821743A0 (it) Materiali biologici, procedimenti per produrre materiali biologici e per usare tali materiali in terapia.
DE3673704D1 (de) Waermeschrumpfbarer laminatfilm und dessen anwendung.
FI830523A0 (fi) Anti-inflammatoriska och/eller smaerta lindrande 2,3-diaryl-5-halotiofener